The Wolverine Stack: BPC-157, TB-500 & Thymosin Alpha-1 Protocol

What Is the Wolverine Stack?#

The Wolverine Stack is a named peptide protocol combining BPC-157, TB-500, and typically Thymosin Alpha-1. The name refers to the Marvel character's accelerated healing factor — an apt metaphor for a stack built entirely around accelerating tissue repair, reducing inflammation, and supporting immune function. It gained widespread popularity in the peptide community for its comprehensive approach to recovery, addressing tissue repair (BPC-157), systemic inflammation (TB-500), and immune optimisation (Thymosin Alpha-1) simultaneously.

Core Wolverine Stack: BPC-157 + TB-500 + Thymosin Alpha-1

Thymosin Alpha-1: The Third Compound#

Thymosin Alpha-1 (TA1) is a naturally occurring thymic peptide that plays a central role in immune regulation. It modulates both innate and adaptive immunity, enhances T-cell function, and has documented anti-inflammatory properties. In the Wolverine Stack, TA1 serves as the immune and systemic recovery component — particularly relevant for users recovering from illness, managing chronic inflammation, or under significant physical stress. Research doses are typically 1-1.6mg subcutaneously, 2-3 times weekly. TA1 is the least essential component and is sometimes omitted in simplified versions of the stack.

Why These Three Compounds Work Together#

Each compound addresses a different dimension of recovery. BPC-157 handles local tissue repair — it works best at injury sites and has a strong affinity for tendon, ligament, and gut healing. TB-500 provides systemic anti-inflammatory coverage and promotes angiogenesis throughout the body. Thymosin Alpha-1 supports the immune system's ability to clear cellular debris, modulate inflammatory signalling, and recover from physical stress. Together they address local repair, systemic inflammation, and immune function — a comprehensive recovery protocol rather than a single-mechanism approach.

Dosing Protocol#

Standard Wolverine Stack protocol: BPC-157 at 250-500mcg once or twice daily (subcutaneous or intramuscular near the site of injury), TB-500 at 5mg twice weekly for 4 weeks (loading) then 2.5mg weekly (maintenance), and Thymosin Alpha-1 at 1.6mg twice weekly. All three can be injected on the same day — some users combine TA1 and TB-500 in the same syringe to minimise injections. Run the full stack for 8-12 weeks.

Reconstitution and Tracking#

All three compounds require reconstitution with bacteriostatic water before injection. Reconstitute each separately in their original vials. Store in the refrigerator after reconstitution. BPC-157 and Thymosin Alpha-1 are stable for approximately 30 days refrigerated. TB-500 is stable for up to 60 days refrigerated. Use the Staqk reconstitution calculator to calculate your exact draw volumes for each compound. Label vials with the date of reconstitution and concentration. Track all three compounds separately — log each injection with date, dose, and site.

Label every vial: compound name, date reconstituted, concentration (e.g. BPC-157 — 28 Feb — 2mg/mL).